Opterion Health AG appoints Björn Englund as CEO
· Opterion Health AG has appointed Björn Englund as CEO, starting in April 2021 · Björn Englund will take over from the founder of Opterion, Guido Grentzmann, who will focus on his role as Chief Scientific Officer (CSO) · Preparation for Phase I at full speed, following the successful Bridge Financing Roundof EUR 8.4m · The relocation of the company to Muttenz (BL) is to be officially conducted in April 2021Sarnen, Switzerland, 25 March 2021 – Opterion Health AG, a preclinical Swiss life science company, developing the first novel solution for peritoneal dialysis (PD) in the last